Focused Update of the Guidelines for the Use of Antiplatelet Therapy


2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the Use of Antiplatelet Therapy 

 Example recommendations: 

- In patients undergoing PCI who are treated with a BMS and who require elective noncardiac surgery, we recommend delaying surgery for at least 1 month after PCI(Strong Recommendation; Moderate-Quality Evidence).

- In patients undergoing PCI who are treated with a DES and who require elective noncardiac surgery, we recommend delaying surgery for at least 3 months after PCI (Strong Recommendation; Moderate-Quality Evidence).

 If there is a need for semiurgent noncardiac surgery, we suggest delaying surgery for at least 1 month after PCI (Weak Recommendation; Low-Quality Evidence).

- In patients undergoing PCI who are treated with either a BMS or DES and who require elective noncardiac surgery, we suggest continuing ASA peri-operatively whenever possible (Weak Recommendation; Low-Quality Evidence).

- In patients undergoing PCI who are treated with a BMS or DES and who require elective noncardiac surgery, we suggest withholding clopidogrel and ticagrelor for 5-7 days preoperatively, and prasugrel

for 7-10 days preoperatively (Weak Recommendation; Low-Quality Evidence).

- In patients undergoing PCI who are treated with a BMS or DES and who have undergone noncardiac surgery, we suggest restarting maintenance-dose DAPT after surgery, as soon as it is deemed safe by the surgeon (Weak Recommendation; Very Low-Quality Evidence).

 

 Download Article : Focused Update of the Guidelines for the Use of Antiplatelet Therapy 

 

 

For more information, please contact Societys secretariat by +9821 22387706